These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 23364625

  • 1. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyó JM, Praga M, Torra R, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2013 Jan 18; 33(1):27-45. PubMed ID: 23364625
    [Abstract] [Full Text] [Related]

  • 2. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Jan 18; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 3. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
    Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC.
    Neth J Med; 2012 Apr 18; 70(3):121-9. PubMed ID: 22516576
    [Abstract] [Full Text] [Related]

  • 4. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan 18; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

  • 5. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Nephrology (Carlton); 2018 Jun 18; 23(6):507-517. PubMed ID: 29419916
    [Abstract] [Full Text] [Related]

  • 6. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Intern Med J; 2018 Jun 18; 48(6):624-636. PubMed ID: 29582550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
    Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B.
    Pediatrics; 2014 Jun 18; 133(6):e1764-8. PubMed ID: 24843055
    [Abstract] [Full Text] [Related]

  • 12. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
    Taylor CM, Machin S, Wigmore SJ, Goodship TH, working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society.
    Br J Haematol; 2010 Jan 18; 148(1):37-47. PubMed ID: 19821824
    [Abstract] [Full Text] [Related]

  • 13. [Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].
    Vaisbich MH, Henriques Ldos S, Watanabe A, Pereira LM, Metran CC, Malheiros DA, Modanez F, Silva JD, Vieira S, Macedo AC, Massarope B, Furusawa EA, Schvartsman BG.
    J Bras Nefrol; 2013 Jan 18; 35(3):237-41. PubMed ID: 24100744
    [Abstract] [Full Text] [Related]

  • 14. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M, Tanabe K.
    Nephrology (Carlton); 2016 Jul 18; 21 Suppl 1():9-13. PubMed ID: 26988663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
    Christmann M, Hansen M, Bergmann C, Schwabe D, Brand J, Schneider W.
    Pediatrics; 2014 Jun 18; 133(6):e1759-63. PubMed ID: 24843059
    [Abstract] [Full Text] [Related]

  • 17. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T, Okumi M, Unagami K, Kanzawa T, Sawada A, Kawanishi K, Omoto K, Ishida H, Tanabe K.
    Nephrology (Carlton); 2016 Jul 18; 21 Suppl 1():35-40. PubMed ID: 26970541
    [Abstract] [Full Text] [Related]

  • 18. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
    Fakhouri F, Frémeaux-Bacchi V, Loirat C.
    Eur J Intern Med; 2013 Sep 18; 24(6):492-5. PubMed ID: 23756030
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.